• Atrys Health has called a December 2, 2026, bondholder meeting to vote on restructuring its convertible bonds.
• Proposed terms extend maturity to September 30, 2033, and cut the conversion price from EUR 7 to EUR 3.25 per share.
• Annual interest would be 8.5%: 4% payable in cash, with 4.5% payable in cash or capitalized at the issuer’s option.
• The bonds would rank below new senior financing, with cash interest suspended and capitalized upon senior financing default or acceleration.
• Implementation requires shareholder authorization, board resolutions and signing of senior financing and an intercreditor agreement by December 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atrys Health SA published the original content used to generate this news brief on November 12, 2026, and is solely responsible for the information contained therein.